Abdulrafeh Naqash to NF-E2-Related Factor 2
This is a "connection" page, showing publications Abdulrafeh Naqash has written about NF-E2-Related Factor 2.
Connection Strength
0.047
-
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer. 2022 08 15; 128(16):3067-3079.
Score: 0.047